Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


25.06.2018

1 Am J Clin Oncol
1 Anticancer Res
1 BMC Cancer
1 Cancer Manag Res
2 Eur Rev Med Pharmacol Sci
1 Front Cell Infect Microbiol
1 Future Oncol
1 Hinyokika Kiyo
1 Hum Gene Ther
1 J Cell Biochem
1 J Spinal Cord Med
1 J Urol
1 Lab Invest
1 Mol Cancer Ther
1 Oncol Lett
1 Sci Adv
1 Sci Rep
3 Transl Androl Urol
1 Transplant Proc
1 Ups J Med Sci
1 Urol Oncol
1 Virchows Arch
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. ZHONG J, Switchenko J, Jegadeesh NK, Cassidy RJ, et al
    Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Am J Clin Oncol. 2018 Jun 16. doi: 10.1097/COC.0000000000000471.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. POSFAI B, Kuthi L, Varga L, Laczo I, et al
    The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.
    Anticancer Res. 2018;38:3243-3254.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. LIU H, He W, Wang B, Xu K, et al
    MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
    BMC Cancer. 2018;18:659.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  4. LIN WY, Wu CT, Chen MF, Chang YH, et al
    Cystectomy for bladder cancer in elderly patients is not associated with increased 30- and 90-day mortality or readmission, length of stay, and cost: propensity score matching using a population database.
    Cancer Manag Res. 2018;10:1413-1418.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  5. WANG Y, Li LJ, Qiu MX, Gong BS, et al
    Effects of paclitaxel combined with miR-448 on growth and proliferation of bladder cancer EJ cells.
    Eur Rev Med Pharmacol Sci. 2018;22:3363-3369.
    PubMed     Text format     Abstract available

  6. LIN MG, Hong YK, Zhang Y, Lin BB, et al
    Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN.
    Eur Rev Med Pharmacol Sci. 2018;22:3370-3377.
    PubMed     Text format     Abstract available


    Front Cell Infect Microbiol

  7. WU P, Zhang G, Zhao J, Chen J, et al
    Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
    Front Cell Infect Microbiol. 2018;8:167.
    PubMed     Text format     Abstract available


    Future Oncol

  8. CLINTON TN, Lotan Y
    The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
    Future Oncol. 2018 Jun 21. doi: 10.2217/fon-2018-0328.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  9. IEMURA Y, Fukui S, Matsumura Y, Kagebayashi Y, et al
    [Bladder Rupture during Intravesical BCG Therapy : A Case Report].
    Hinyokika Kiyo. 2018;64:25-28.
    PubMed     Text format     Abstract available


    Hum Gene Ther

  10. LICHTENEGGER E, Koll F, Haas H, Mantwill K, et al
    The oncolytic Adenovirus XVir-N-31 as a novel therapy in muscle-invasive bladder cancer.
    Hum Gene Ther. 2018 Jun 19. doi: 10.1089/hum.2018.
    PubMed     Text format     Abstract available


    J Cell Biochem

  11. HE C, Zhang Q, Gu R, Lou Y, et al
    miR-96 regulates migration and invasion of bladder cancer through epithelial-mesenchymal transition in response to transforming growth factor-beta1.
    J Cell Biochem. 2018 Jun 19. doi: 10.1002/jcb.27172.
    PubMed     Text format     Abstract available


    J Spinal Cord Med

  12. FITZPATRICK R, Baverstock R
    Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf's clothing.
    J Spinal Cord Med. 2018 Jun 20:1-4. doi: 10.1080/10790268.2018.1487188.
    PubMed     Text format     Abstract available


    J Urol

  13. DOWNS TM, Weissert JA, Ravvaz K
    Can we improve non-muscle-invasive bladder cancer (NMIBC) guideline adherence with smarter risk-stratification?
    J Urol. 2018 Jun 12. pii: S0022-5347(18)43357-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format    


    Lab Invest

  14. CHEN Z, Zhou L, Liu X, Wang L, et al
    Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-kappaB signaling pathway.
    Lab Invest. 2018 Jun 20. pii: 10.1038/s41374-018-0077.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  15. WOOLBRIGHT BL, Choudhary D, Mikhalyuk A, Trammel C, et al
    The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
    Mol Cancer Ther. 2018 Jun 15. pii: 1535-7163.MCT-18-0063.
    PubMed     Text format     Abstract available


    Oncol Lett

  16. ZHANG L, Feng C, Zhou Y, Zhou Q, et al
    Dysregulated genes targeted by microRNAs and metabolic pathways in bladder cancer revealed by bioinformatics methods.
    Oncol Lett. 2018;15:9617-9624.
    PubMed     Text format     Abstract available


    Sci Adv

  17. KANEKO S, Li X
    X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism.
    Sci Adv. 2018;4:eaar5598.
    PubMed     Text format     Abstract available


    Sci Rep

  18. LORAS A, Trassierra M, Sanjuan-Herraez D, Martinez-Bisbal MC, et al
    Bladder cancer recurrence surveillance by urine metabolomics analysis.
    Sci Rep. 2018;8:9172.
    PubMed     Text format     Abstract available


    Transl Androl Urol

  19. FANKHAUSER CD, Mostafid H
    Genetic polymorphisms may explain association between alcohol consumption and bladder cancer risk in East Asian men.
    Transl Androl Urol. 2018;7.
    PubMed     Text format    

  20. SANGUEDOLCE F, Cormio L
    The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.
    Transl Androl Urol. 2018;7.
    PubMed     Text format    

  21. LIM C, Cohn JR, Cohn JA
    Can a diagnosis of bladder cancer motivate positive lifestyle changes-and prevent recurrent disease?
    Transl Androl Urol. 2018;7.
    PubMed     Text format    


    Transplant Proc

  22. NORTH D, Jaw J, Hill P, Bateman S, et al
    Nephrogenic Adenoma Complicating Renal Transplantation: A Case Report and Discussion.
    Transplant Proc. 2017;49:2381-2383.
    PubMed     Text format     Abstract available


    Ups J Med Sci

  23. KOK VC, Zhang HW, Lin CT, Huang SC, et al
    Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals.
    Ups J Med Sci. 2018 Jun 18:1-7. doi: 10.1080/03009734.2018.1473534.
    PubMed     Text format     Abstract available


    Urol Oncol

  24. GHODOUSSIPOUR S, Daneshmand S
    Current controversies on the role of lymphadenectomy for bladder cancer.
    Urol Oncol. 2018 Jun 14. pii: S1078-1439(18)30157.
    PubMed     Text format     Abstract available


    Virchows Arch

  25. KULAC I, Arslankoz S, Netto GJ, Ertoy Baydar D, et al
    Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Virchows Arch. 2018;472:969-974.
    PubMed     Text format     Abstract available


    World J Urol

  26. THIEL T, Ryk C, Renstrom-Koskela L, Steineck G, et al
    Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer.
    World J Urol. 2018 Jun 15. pii: 10.1007/s00345-018-2375.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: